The Latest Breaking News from Obesity

Numerous studies have shown that social isolation and loneliness are associated with an increased risk of early death, on a scale comparable to other known risk factors such as smoking and obesity. This year, the US surgeon general declared social isolation and loneliness to be a significant public health concern.

A new generation of obesity drugs often delivers dramatic weight loss, but many patients wonder what happens when they stop treatment.

‘They gain back about half the weight they had originally lost over a one-year period of time,’ professor says

Eli Lilly stock skidded Monday after a new study showed patients who stopped taking its weight-loss drug slowly regained weight over a year.

A preclinical study conducted by Weill Cornell Medicine researchers reveals that a certain human genetic variant of a receptor that increases insulin release may help individuals be more resistant to obesity. Read further on Dynamite News:

Groundbreaking study suggests type 2 diabetes medications may also ward off other obesity-related cancers

Letter: It’s easy to blame individuals, but real change can only happen if industry and the government take responsibility, says Colette Marshall of Diabetes UK. Plus a letter from Michael Fuller

The male supermodel talks to Helen Coffey about body image, how he lost his ‘puppy fat’, his new ‘influencer’ rivals and protecting his daughters from the evils of social media in the age of the internet

In London, a ban on fast-food takeaways opening within 400 metres of schools was put in place in 2017

Alzheimer's disease rates rise in these countries as they make the nutrition transition to the Western diet. Read further on Dynamite News:

Earlier this month, the FDA approved Eli Lilly's Zepbound, a drug similar to its diabetes drug Mounjaro but specifically advertised for weight loss.